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Atsushi Takenaka
Division of Urology, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan
ABSTRACT
Background    Dysfunction of the lower urinary tract is 
the most common complication of radical hysterectomy 
(RH). However, there are no established treatment 
protocols for postoperative underactive bladder (PUB). 
We developed our own new program for the treatment 
of underactive bladder (UB) after RH and evaluated it 
retrospectively.
Methods    In this program, there are five steps for pa-
tients to follow according to their urinary condition. The 
first step is the administration of urapidil 30 mg, voiding 
six times at a predetermined time each day, and clean 
intermittent catheterization (CIC) after each voiding. As 
the patient’s condition improves, the number of CICs is 
reduced, and the medication is stopped. The last step 
includes voiding six times at a predetermined time each 
day. When the volume of residual urine (RU) is less than 
100 mL, patients move on to the next step. When the 
volume of RU exceeds 100 mL, patients return to the 
previous step.
Results    Of the 75 patients who visited our department, 
41 were eligible for this program. Twenty-two patients 
visited our department because of urinary retention (UR), 
and 19 patients were admitted because of increased RU. 
The mean RU volume was 276.3 mL (range, 150–550 
mL). After completing the program, 39 (95.1%) patients 
no longer required CIC. The mean time to withdrawal 
of CIC was 25.1 weeks (range, 1–72 weeks). Thirty-six 
patients no longer required medical treatment, including 
urapidil, for PUB. Of the 5 patients who had persistent 
PUB after treatment, 2 patients continued CIC and ura-
pidil, and three patients continued urapidil alone.
Conclusion    The present results demonstrate that the 
program of CIC in combination with urapidil is effective 
for the management of PUB after RH.
  
Key words    Clean intermittent catheterization; radical 
hysterectomy; underactive bladder
Underactive bladder (UB) is a clinical entity often en-
countered by urologists and is often associated with sig-
nificant lower urinary tract symptoms. The International 
Continence Society has defined detrusor underactivity 
as “a contraction of reduced strength and/or duration, 
resulting in prolonged bladder emptying and/or failure 
to achieve complete bladder emptying within a normal 
time span.”1
 During surgery, the nerves involved in urinary 
function are sometimes injured.2 In particular, surgery 
involving the uterus can result in postoperative under-
active bladder (PUB).3 Surgeries for malignant tumors 
require complete resection of the tumor and sometimes 
require the sacrifice of some surrounding nerves. The 
greater the surgical stress, the more extensive is the 
nerve damage, sometimes resulting in severe urinary 
dysfunction, such as PUB, and rectal disorders.3 In 
recent years, nerve-sparing surgical techniques have 
been developed.4 In PUB, the attenuation of micturition 
after catheter removal is usually recognized by the 
disappearance of urinary sensation and lower abdominal 
distention. Detrusor muscle contraction in PUB reduces 
dysuria or urinary retention (UR). Because the effect of 
drug therapies is limited, some patients require clean 
intermittent catheterization (CIC) to facilitate bladder 
emptying.3
 Dysfunction of the lower urinary tract is the most 
common complication of radical hysterectomy (RH). 
However, there is no established treatment protocol for 
PUB. Therefore, we created our own program for PUB 
after RH. We formulated this program so that it can be 
safely followed at the generalist’s level without referral 
to the urologist. The final goal of this program was 
withdrawal from CIC and pharmacological treatment 
with alpha-blockers. This program was evaluated retro-
spectively.
MATERIALS AND METHODS
Ethics
This study was conducted at the Division of Urology, 
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Tottori University Hospital, Tottori, Japan. The 
study was approved by the Tottori University Ethics 
Committee (no. 17A100).
Patients
Female patients who underwent RH for endometrial 
and cervical uterine cancer between January 2010 and 
April 2015 at our department were included in the study. 
Patients were excluded if they had active urinary tract 
infections (UTIs) and/or preoperative neurogenic blad-
der. All patients were referred to our treatment program 
after a diagnosis of PUB.
Program for PUB
The program involved five steps. The first step included 
the administration of urapidil 30 mg, voiding six times at 
a predetermined time each day, and CIC after each void-
ing. The second step involved the administration of ura-
pidil 30 mg, voiding six times at a predetermined time 
each day, and CIC three times per day after voiding. The 
third step involved the administration of urapidil 30 mg, 
voiding six times at a predetermined time each day, and 
CIC once per day after voiding. The fourth step involved 
treatment with urapidil 30 mg and voiding six times at 
a predetermined time each day. From the fourth step to 
the last step, residual urine was measured at the outpa-
tient clinic visit for the prescription of oral urapidil, and 
the amount of residual urine was the key factor: when 
patients’ residual urine became less than 100 mL, they 
stopped urapidil. The last step involved voiding six times 
Step 1 Urapidil 30 mg + void six times per day + CIC after each voiding
Volume of residual urine less than 100 mL
Step 2 Urapidil 30 mg + void six times per day + CIC three times per day after voiding
Volume of residual urine less than 100 mL
Step 3 Urapidil 30 mg + void six times per day + CIC once per day after voiding
Volume of residual urine less than 100 mL
Step 4 Urapidil 30 mg + void six times per day 
Volume of residual urine less than 100 mL
Step 5 Voiding six times per day
Fig. 1. Program for postoperative underactive bladder. The first 
step is taking urapidil 30 mg, voiding six times per day, and CIC 
after each voiding. The last step is voiding six times per day. If 
the volume of residual urine is over 100 mL, patients return to the 
previous step. CIC, clean intermittent catheterization.
at a predetermined time each day. When the volume of 
residual urine was less than 100 mL, patients were asked 
to move on to the next step. When the volume of residual 
urine exceeded 100 mL, patients were asked to return to 
the previous step (Fig. 1).
RESULTS
Of the 75 patients who visited our department during 
the study period, 41 were eligible for this program. 
All patients reported reduced bladder sensation and 
required urethral catheterization or CIC because of UR 
or increased residual urine (RU). The mean patient age 
was 48.3 years (range, 31–71 years). Thirty-nine patients 
were diagnosed with cervical cancer (stage I: 21 patients, 
stage II: 18 patients), and two had endometrial uterine 
cancer. All patients underwent RH and pelvic lymph 
node dissection, with or without ovariectomy. None of 
the patients underwent nerve-sparing surgery. The mean 
number of postoperative days to urethral catheter remov-
al was 7.4 days (range, 6-16 days). Twenty-two patients 
visited our department because of UR, and 19 patients 
were admitted because of increased RU. The mean RU 
volume was 276.3 mL (range, 150–550 mL). Thirty-six 
patients started Step 1. Five patients could not use ura-
pidil because of low blood pressure, so they started the 
program with voiding six times per day and CIC after 
each voiding (Table 1). 
Table 1. Patients’ characteristics
N = 41
Age, y (range) 48.3 (31–72)
Cervical cancer Stage  Ib 2
Endometrial cancer Stage  Ib1 16
Stage  Ib2 5
Stage IIa 3
Stage  IIb 15
Time to removal of urethral catheter, days (range) 7.4 (6–16)
Initial treatment
CIC + urapidil 36
CIC only 5
Urinary dysfunction 
Urinary retention 22
Increased residual 
urine 19
Mean residual urine volume, mL (range) 276.3 (50–550)
CIC, clean intermittent catheterization; y, years.
 After completing the program, 39 (95.1%) patients 
no longer required CIC after voiding. The mean time to 
withdrawal of CIC was 25.1 weeks (range, 1–72 weeks). 
Thirty-six patients no longer required medical treatment, 
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including urapidil, after this program. Five patients re-
quired ongoing medical treatment for PUB; two patients 
continued CIC and urapidil, and three continued urapidil 
alone (Fig. 2, Table 2).
 Adverse events of this program included UTIs. 
Acute cystitis occurred in four patients, and acute py-
elonephritis developed in one patient who subsequently 
required hospitalization.
DISCUSSION
The pelvic nerve plexus has visceral terminal branches 
that innervate the bladder. Pelvic surgery, such as RH, 
can cause nerve injury and lead to PUB. RH is the most 
common surgical treatment for uterine cervical cancer 
and stage II uterine endometrial cancer. After RH, it has 
been reported that the overall incidence of detrusor dys-
function is 8-80%.3 Sensory loss and voiding disorders 
are the primary conditions. Thus, some patients require 
urethral catheterization or CIC. For patients with UB, 
clinicians should consider restoring optimal bladder 
function and emptying. Currently, the most important 
treatment for UB is mechanical bladder emptying, such 
as CIC. Patients with an acontractile detrusor muscle 
void by increasing abdominal pressure, but some RU 
usually remains. Patients who exert high abdominal 
pressures while voiding may trigger a vesicoureteral 
refl ex and develop upper urinary tract dysfunction. CIC 
defers the progression of upper urinary tract damage, 
avoids bladder overdistention, and reduces RU.2
 Generally, early transient postoperative changes con-
sist of reduced bladder capacity, detrusor underactivity, 
and diminished bladder sensation, which cause voiding 
dysfunction and may require urethral catheterization or 
CIC. Late changes include emptying diffi culties, irritable 
symptoms of frequency, urgency, and urge incontinence, 
and reduced bladder capacity for 6-12 months or longer.5 
The purpose of this program is not to shorten the treat-
ment period, but to restore bladder function in a period 
equivalent to treatment without a specialist. All patients 
should be referred to a urologist, but this is sometimes 
difficult. The present study evaluated the program we 
developed, whose aim is to be able to do the proper 
treatment without the urologist.
 In this program, the voiding frequency was set at six 
times per day because it has been traditionally suggested 
that the ideal or optimal frequency of CIC was every 
4–6 h, with goal residual volumes of less than 500 mL.6
 The pharmacological treatment of UB is limited. 
Muscarinic receptor agonists can sometimes be used for 
UB. However, six randomized trials found no signifi cant 
improvement in voided volume, RU, and fl ow rate com-
pared with placebo or no treatment. On the other hand, 
even though the level of evidence was low, alpha-blockers 
may constitute an acceptable first-line therapy for pa-
tients with UB7; therefore, urapidil was chosen for our 
program. If possible, all patients were considered for 
urapidil, but some of the patients could not take urapidil 
due to low blood pressure. There was a possibility of 
early recovery, but because the number in this study 
was small, it was diffi cult to compare patients who did 
or did not use urapidil. Therefore, it was not possible to 
determine if urapidil was really necessary.
 In the present study, although some of the patients’ 
RU volumes were small, the mean time to withdrawal 
of CIC was 25.1 (range, 1–72) weeks. Generally, acute 
voiding symptoms disappear within 6–12 months 
after RH.5 The results of the present study suggest that 
bladder function recovers after approximately 6 months. 
However, pressure flow studies (PFS) were not per-
formed in all cases. Therefore, it was unclear whether 
Table 2. Patients who required continuing medical 
treatment for postoperative underactive bladder
No. in 
Fig. 2 Age (y) UR or RU US DMC
Withdrawal of 
CIC
6 45 UR No Acontractile Yes
7 35 UR No Acontractile Yes
11 32 UR No Acontractile No
26 40 RU Yes Very weak No
27 48 UR No Very weak Yes
CIC, clean intermittent catheterization; DMC, detrusor muscle 
contraction; RU, residual urine; UR, urinary retention; US, uri-
nary sensation; y, years.
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Fig. 2. 
 
 
 
CIC + urapidil or CIC only 
Urapidil	  
Week 
Fig. 2. Results of the postoperative underactive bladder treatment 
program. The number of patients who did not require CIC after 
this program is 39 (95.1%). The mean time to withdrawal of CIC 
is 25.1 (range, 1–72) weeks. Among the fi ve patients continuing 
medical treatment for postoperative underactive bladder, two 
patients continued CIC and urapidil, and three patients continued 
urapidil. CIC, clean intermittent catheterization.
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bladder function was actually restored.
 As for cases of difficulty in withdrawal of CIC, pre-
vious reports have suggested that bladder function was 
delayed after postoperative radiotherapy.8 In the present 
study, two patients required continuing CIC. The char-
acteristics of patients who needed to continue treatment 
were unknown. Surgical technique and radiation therapy 
were also not involved. In the future, if the number of 
cases increases, it may be possible to determine the 
characteristics of patients who fail to recover fully. This 
is a limitation of this study.
 These patients eventually achieved self-voiding but 
required continuing CIC because of increased RU. The 
reason for these results is unknown, but these patients 
may have sustained extensive nerve injuries intraopera-
tively.
 The most common complication of CIC is UTI.9 
Since there was only one case of severe UTI during 
the study, our patient education program when patients 
started CIC, run by the nursing staff, was considered 
effective.10 In this regard, we consider that our program 
can be operated relatively safely.
 One limitation of this study is its small number of 
patients, but the program is still ongoing and gradually 
accumulating more cases. Another limitation is the issue 
of long-term follow-up. Some patients discontinued 
follow-up. Additionally, PFS was not performed after 
withdrawal of CIC in all patients. The recovery of blad-
der function was evaluated in all patients, irrespective 
of whether they voided using increased abdominal pres-
sure.
 In the present study, 22 patients had UR, but only 
two needed continuing CIC after completing this 
program, indicating its usefulness in such patients. The 
completion of each step was decided only by the RU 
volume, a concept that can be easily understood and 
determined by the patients themselves during CIC. By 
educating each patient about each step in advance, the 
patient can make any adjustments as necessary. The 
implementation of this program was done without much 
difficulty with respect to the patients’ participation or 
the nurses’ and doctors’ contributions.
 The present results demonstrate that the program 
of CIC in combination with urapidil is effective for the 
management of PUB after RH.
The authors declare no conflict of interest.
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